HOME >> MEDICINE >> NEWS
Mayo Clinic finds kidney disease associated with 'benign' prostate obstruction

ROCHESTER, Minn. -- Men who experience signs and symptoms of a prostate obstruction resulting from benign prostatic hyperplasia (BPH) are three times more likely than other men to develop chronic kidney disease, according to findings of a Mayo Clinic study published in this month's edition of Kidney International.

"This is the first study on the topic to sample the general community," says Andrew Rule, M.D., the Mayo Clinic kidney specialist who conducted the study with epidemiologist Steven Jacobsen, M.D., Ph.D.

"Symptomatic and non-symptomatic men were compared, unlike clinical trials and studies in a urology practice, which tend to represent only symptomatic men."

BPH and chronic kidney disease pose significant health problems in older men. Chronic kidney disease (CKD) occurs when the kidneys cannot rid metabolic wastes from the body or maintain the proper fluid and chemical balances. Eventually, the waste builds up and becomes poisonous to the body. Kidney disease can develop rapidly - in two to three months - or gradually over decades.

Many risks coincide with the development of CKD. "Several studies show men with chronic kidney disease have increased chance of death, hospitalization and cardiovascular events," says Dr. Rule.

The prostate gland is located just below a male's bladder and surrounds the top portion of the urethra, the tube that drains urine from the bladder. "Growth of the prostate gland can lead to a bladder outlet obstruction," says Dr. Rule. "An obstruction of the bladder can cause inability to or discomfort in emptying the bladder, a slowed stream of urine, frequent urges to void during the night or an enlarged, damaged bladder."

"We were surprised at how much kidney disease can be attributed to BPH," says Dr. Jacobsen. "An obstruction on the urethra is like a dam on a river - men can still void, but the constant buildup and pressure will ultimately cause damage." BPH affects about half o
'"/>

Contact: Lisa Lucier or Marissa Mulford
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
28-Jun-2005


Page: 1 2

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. New Mayo Clinic MRI technology enables noninvasive liver diagnoses
6. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
7. Elsevier launches the Clinics on ScienceDirect
8. Clinical guidelines for blood conservation during cardiac procedures developed
9. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
10. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
11. Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression

Post Your Comments:
(Date:5/21/2013)... Bradley, Illinois (PRWEB) May 21, 2013 ... living community], a BMA affordable assisted living community, is hosting ... Don'ts of Arthritis at 2 p.m. on Tuesday, May 28. ... in Dwight, Illinois, serves older adults of all incomes, including ... independence. , The Arthritis program is open to the public. ...
(Date:5/21/2013)... Medical Ministry International announced today that it ... GreatNonprofits , the leading provider of user reviews about ... Top-Rated 2013 Nonprofit,” says Samuel Smith, MMI CEO. This ... Volunteers and Staff serving in 22 countries around the world. ... that have seen our work first hand and wanted to ...
(Date:5/21/2013)... (May 21, 2013) Prostaglandin analogues (PGAs), drugs which ... treatment for people with glaucoma, but their use is ... blurred vision, dryness, changes in eye color and other ... these drugs also cause upper and lower eyelid drooping ... findings are described in PLOS ONE . , ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Artisan ... EB-5 Investment Summit: Dealmakers Conference in Long Beach, ... will focus on exploring alternative finance through EB-5 ... latest market, legal and economic information, and updates ... legal professionals within the EB-5 industry. , ...
(Date:5/21/2013)... 2013 The federal judge overseeing the ... lawsuits in U.S. District Court, Northern District of ... request from Plaintiffs’ Counsel to conduct Ex Parte interviews ... 17th Order grants that request, and sets forth procedures ... Wright Medical Technology, Inc., Conserve Hip Implant Products Liability ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis 2Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2Health News:Glaucoma drug can cause droopy eyelids 2Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3
(Date:5/22/2013)... , May 22, 2013 Assured Pharmacy, ... providing prescription medications to sufferers of chronic pain, announced ... recognized, national investor relations firm, to raise its visibility ... "Over the past year, we have proven our ... recently announced plans to open two additional new pharmacies ...
(Date:5/22/2013)... VANCOUVER, British Columbia , May 22, 2013 /PRNewswire/ ... in the development of novel therapeutics to target mechanisms of ... its investigational compounds, custirsen and OGX-427, will be presented as ... Meeting of the American Society of Clinical Oncology (ASCO) in ... June 4. Despite the availability of drugs ...
(Date:5/22/2013)... , May 22, 2013 WomanCare Global ... with an extensive training initiative attended by ... http://photos.prnewswire.com/prnh/20130522/DC18844 ) (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) ... is a highly effective subdermal implant composed of ... mg levonorgestrel (a synthetic form of the hormone ...
Breaking Medicine Technology:Assured Pharmacy Hires Hayden IR 2Assured Pharmacy Hires Hayden IR 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2
Cached News: